Figure 6

Congaplex ^® and Immuplex ^® do not decrease the number of viable PBMCs at 0.5 mg/mL. PBMCs from a healthy volunteer were treated with Congaplex^® and Immuplex^® at 0.5 mg/mL for 1 hour prior to the addition of PHA. After 24 hours of treatment with PHA the number of viable cells was measured as described in Materials and Methods. Data were normalized to the relative fluorescence units for the vehicle treatment. Data represents the average of three replicates ± standard deviation. * = significantly different from the vehicle treatment.